Avio (ex-Bartronics) lifts Huwel Lifesciences stake to 2.06% for ₹75M
What's the deal? Avio Smart Market StackDealroom has a profile for this one. Try Dealroom → (formerly Bartronics India) has acquired a 2.06% stake in Huwel LifesciencesDealroom has a profile for this one. Try Dealroom →, an Indian molecular diagnostics maker, for ₹75,000,400 in cash. The disclosure covers an arm's-length purchase of 9,665 equity shares at ₹7,760 each, including a ₹7,750 premium per share.
The update: The figure revises Avio's earlier disclosed investment of ₹40,000,000, confirming a larger commitment than previously reported. Avio said it made the acquisition to derive operational and financial synergies, and that the deal does not fall within related-party transactions, with its promoter group holding no interest in Huwel.
What's the endgame? Huwel, incorporated in February 2015 and based in Patancheru, Telangana, develops, manufactures and supplies molecular diagnostic kits, medical devices and in-vitro diagnostic solutions, serving hospitals, laboratories and research institutions for disease detection and healthcare testing.
The numbers: Huwel's turnover has moved unevenly, from ₹12.11 crore in 2022-23 to ₹4.94 crore in 2023-24, before rising to ₹15.74 crore in 2024-25.
The signal: The move gives Avio a small foothold in India's diagnostics sector as demand for molecular testing continues to draw investment.
Read more: Investoo Market
Image credit: IAEA Imagebank
